Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

Færch, Kristine, Vistisen, Dorte, Pacini, Giovanni, Torekov, Signe S., Johansen, Nanna B., Witte, Daniel R., Jonsson, Anna, Pedersen, Oluf +5 more·2016·Diabetes

Cited by (217)

Items 101–200 of 217

  1. Role of fasting duration and weekday in incretin and glucose regulation
    Kim Katrine Bjerring Clemmensen, Jonas Salling Quist, Dorte Vistisen, Daniel R. Witte, Anna Elisabet Jonsson, Oluf Borbye Pedersen, Torben F. Hansen, Jens Juul Holst, Torsten Lauritzen, Marit E. Jørgensen et al. · 2020 · Endocrine Connections
  2. No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial
    Kim Katrine Bjerring Clemmensen, Martin Bæk Blond, Hanan Amadid, Lea Bruhn, Dorte Vistisen, Kristian Karstoft, Frederik Persson, Mathias Ried‐Larsen, Jens Juul Holst, Nicolai J. Wewer Albrechtsen et al. · 2020 · Diabetes Obesity and Metabolism
  3. Food protein-derived bioactive peptides for the management of nutrition related chronic diseases
    Xinyi Cao, Wang Liao, Shaokang Wang · 2022 · Advances in food and nutrition research
  4. Insulin secretion and action and the response of endogenous glucose production to a lack of glucagon suppression in nondiabetic subjects
    Adams, Jon D., Egan, Aoife M., Laurenti, Marcello C., Schembri Wismayer, Daniel, Bailey, Kent R., Cobelli, Claudio, Dalla Man, Chiara, Vella, Adrian · 2021 · American Journal of Physiology-Endocrinology and Metabolism
  5. The Longitudinal Effect of Diabetes-Associated Variation in <i>TCF7L2</i> on Islet Function in Humans
    Zeini, Maya, Laurenti, Marcello C., Egan, Aoife M., Muthusamy, Kalpana, Ramar, Anisha, Vella, Emma, Bailey, Kent R., Cobelli, Claudio, Dalla Man, Chiara, Vella, Adrian · 2024 · Diabetes
  6. Heterogeneous endocrine cell composition defines human islet functional phenotypes
    Carmella Evans‐Molina, Yasminye D. Pettway, Diane C. Saunders, Seth A. Sharp, Thomas S. R. Bate, Han Sun, Heather H. Durai, Shaojun Mei, Anastasia Coldren, Corey Davis et al. · 2026 · Nature Communications
  7. Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans
    Andrew A. Welch, Rahele A. Farahani, Aoife Maria Egan, MARCELLO C. LAURENTI, MAYA ZEINI, Max Vella, Kent R. Bailey, Claudio Cobelli, Chiara Dalla Man, Aleksey V. Matveyenko et al. · 2023 · Journal of Clinical Investigation
  8. An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effect
    Vijaya Subramanian, Jonatan Ising Bagger, Vinayak Harihar, Jens Juul Holst, Filip Krag Knop, Tina Villsbøll · 2023 · American Journal of Physiology-Endocrinology and Metabolism
  9. Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy
    Francesca Urbano, Antonino Di Pino, Roberto Scicali, Agnese Filippello, Stefania Di Mauro, Alessandra Scamporrino, Simona Marchisello, Agata Maria Rabuazzo, Francesco Purrello, Salvatore Piro · 2019 · European Journal of Endocrinology
  10. Genetic and clinical characterization of familial renal glucosuria
    Lubin Xu, Ruohuan Zhao, Yumo Zhao, Xueqing Tang, Nuo Si, Xiuzhi Guo, Cai Yue, Min Nie, Limeng Chen · 2023 · Clinical Kidney Journal
  11. Pancreatic and gut hormones as predictors of new-onset prediabetes after non-necrotising acute pancreatitis: a prospective longitudinal cohort study
    Sakina H. Bharmal, Wandia Kimita, Juyeon Ko, Maxim S. Petrov · 2021 · Endocrine Connections
  12. Obesity and Insulin Resistance: A Review of Molecular Interactions
    Habib Yaribeygi · 2021 · Current Molecular Medicine
  13. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
    Katharina Maruszczak, Konrad Radzikowski, Sebastian Schütz, Harald Mangge, Peter Bergsten, Anders H. Forslund, Hannes Manell, Thomas Pixner, Håkan K. Ahlström, Joel Kullberg et al. · 2022 · Frontiers in Endocrinology
  14. Abnormal Glucagon Secretion Contributes to a Longitudinal Decline in Glucose Tolerance
    Sneha Mohan, Hannah E. Christie, MARCELLO C. LAURENTI, Aoife Maria Egan, Kent R. Bailey, Claudio Cobelli, Chiara Dalla Man, Adrian V Vella · 2025 · The Journal of Clinical Endocrinology & Metabolism
  15. Cytosolic phosphoenolpyruvate carboxykinase is expressed in α‐cells from human and murine pancreas
    Francisco Westermeier, Todd Holyoak, Rodrigo Gatica, Fernando Martínez, Marianne Negrón, Alejandro J. Yáñez, Daniel Nahmias, Francisco Nualart, Ian E. Burbulis, Romina Bertinat · 2019 · Journal of Cellular Physiology
  16. Assessment of Two Different Glucagon Assays in Healthy Individuals and Type 1 and Type 2 Diabetes Patients
    Martina Brunner, Othmar Moser, Reingard Raml, Maximilian Haberlander, Beate Boulgaropoulos, Barbara Maria Obermayer-Pietsch, Eva Švehlíková, Thomas Rudolf Pieber, Harald Sourij · 2022 · Biomolecules
  17. A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
    Vijaya Subramanian, Jonatan Ising Bagger, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll · 2022 · Frontiers in Physiology
  18. Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo
    Francesco Andreozzi, Concetta Di Fatta, Rosangela Spiga, Gaia Chiara Mannino, Elettra Mancuso, Carolina Averta, Carmen De Caro, Martina Tallarico, Antonio Leo, Rita Citraro et al. · 2022 · Diabetes Obesity and Metabolism
  19. Association of Glucagon With Obesity, Glycemic Control and Renal Function in Adults With Type 2 Diabetes Mellitus
    Hidetaka Hamasaki, Shingo Morimitsu · 2020 · Canadian Journal of Diabetes
  20. Associations between peripheral blood mitochondrial genomic variants and gestational diabetes mellitus and postpartum abnormal glucose metabolism
    Qing Luo, Jiankun Zhou, Haiyun Wu, Xia Qiu, Chunyan Xian, Xiaoting Zhan, Jinbo Liu · 2025 · Journal of Diabetes Investigation
  21. Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells
    Antonia Ruiz-Pino, Arianna Goncalves-Ramírez, Margarita Jiménez-Palomares, Beatriz Merino, Manuel Castellano-Muñoz, Jean Franciesco Vettorazzi, Alex Rafacho, Laura Marroquí, Ángel Nadal, Paloma Alonso‐Magdalena et al. · 2024 · Pflügers Archiv - European Journal of Physiology
  22. The relationship between insulin and glucagon concentrations in non‐diabetic humans
    MARCELLO C. LAURENTI, Praveer Arora, Chiara Dalla Man, James C. Andrews, Robert A. Rizza, Aleksey V. Matveyenko, Kent R. Bailey, Claudio Cobelli, Adrian V Vella · 2022 · Physiological Reports
  23. Hyperglucagonemia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - A study from South India
    Satyavani Kumpatla, Rizwana Parveen, Premalatha Murugan, Udyama Juttada, Arutselvi Devarajan, Vijay Viswanathan · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  24. Glucagon in glucose homeostasis and metabolic disease: from physiology to therapeutics
    Abdulbasit Amin, Toyin Mohammed Salman · 2025 · Journal of Basic and Clinical Physiology and Pharmacology
  25. β-cell-specific deletion of PFKFB3 restores cell fitness competition and physiological replication under diabetogenic stress
    Jie Min, Feiyang Ma, Berfin Seyran, Matteo A. Pellegrini, Oppel B.W. Greeff, Salvador Moncada, Slavica Tudzarova · 2022 · Communications Biology
  26. Hypoglycemic effects of white hyacinth bean polysaccharide on type 2 diabetes mellitus rats involvement with entero-insular axis and GLP-1 via metabolomics study
    Yixuan Wang, Jin-Chan Pi, Yu-Fei Yao, Xiaoping Peng, Wenjuan Li, Mingyong Xie · 2024 · International Journal of Biological Macromolecules
  27. Brain insulin signaling and cognition: possible links
    Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2023 · EXCLI journal
  28. A prospective study on glucagon responses to oral glucose and mixed meal and 7‐year change in fasting glucose
    Anitra D.M. Koopman, Joline W. J. Beulens, Amber van der Heijden, Petra J. M. Elders, Jacqueline M. Dekker, Marjan Alssema, Femke Rutters · 2019 · Clinical Endocrinology
  29. Variation in plasma glucagon levels according to obesity status in Japanese Americans with normal glucose tolerance
    Yoshimi Morita, Haruya Ohno, Kazuhiro Kobuke, Kenji Oki, Masayasu Yoneda · 2020 · Endocrine Journal
  30. Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations
    Lingyu Zhang, Yao Qin, Yiting Huang, Qizhen Hu, Qian Wu, Xing Wang, Mei Zhang · 2024 · Frontiers in Endocrinology
  31. Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations
    Vijaya Subramanian, Arthur Sherman, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll, Jonatan Ising Bagger · 2025 · Diabetologia
  32. Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study
    Isabel Pozuelo-Sanchez, Alejandro Villasanta‐Gonzalez, Juan Francisco Alcala-Diaz, Cristina Vals‐Delgado, Ana Leon‐Acuña, Anabel Gonzalez-Requero, Elena M. Yubero‐Serrano, Raul Miguel Luque, Javier Caballero‐Villarraso, Iván Quesada et al. · 2020 · Journal of Agricultural and Food Chemistry
  33. Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review
    Evangelia Tzeravini, Stamatia Simati, Ioanna A. Anastasiou, Μaria Dalamaga, Alexander D. Kokkinos · 2026 · Current Obesity Reports
  34. Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon
    Camilla L Asferg, Ulrik Bjørn Andersen, Allan R Linneberg, Jens Peter Goetze, Jens Juul Holst, Jørgen Jeppesen · 2018 · Diabetic Medicine
  35. Insulin Regulation of Lysine and α-Aminoadipic Acid Dynamics and Amino Metabolites in Women With and Without Insulin Resistance
    Alice Y. Chang, Aneesh Kumar Asokan, Antigoni Z. Lalia, Dhananjay S. Sakrikar, Ian R. Lanza, Xuan-Mai T. Petterson, K. Sreekumaran Nair · 2024 · Diabetes
  36. Dogs fed a high protein, low carbohydrate diet have elevated postprandial plasma glucagon and amino acid concentrations and tend to have lower glucose concentrations compared to two different moderate protein, moderate carbohydrate diets
    Sydney Banton, Shari Raheb, Pawanpreet Singh, John P. Cant, Anna Kate K Shoveller · 2025 · Translational Animal Science
  37. Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
    María M. Adeva-Andany, C. Fernández-Fernández, Lucía Adeva-Contreras, Natalia Carneiro-Freire, A. Domínguez-Montero, D. Mouriño-Bayolo · 2020 · Current Cardiology Reviews
  38. Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study
    Bibi Uhre Nielsen, Inger Hee Mabuza Mathiesen, Rikke Møller, Rikke Krogh‐Madsen, Terese Lea Katzenstein, Tacjana Pressler, James Shaw, Christian Ritz, Michael Roehrhoff Rickels, Darko Stefanovski et al. · 2023 · Frontiers in Endocrinology
  39. Insulin Sensitivity, Islet Cell Function, and Incretin Axis in Pregnant Women With and Without Gestational Diabetes Mellitus
    Niya Narayanan, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Haritha Sagili, Zachariah Bobby, Dukhabandhu Naik, Ayan Roy, Chandhana Merugu · 2024 · Indian Journal of Endocrinology and Metabolism
  40. A collectanea of food insulinaemic index: 2023
    Sriwathi Angeline Hendricks, Mugabe Jean Paul, Yuganeswary Subramaniam, Bhuwaneswaran Vijayam · 2024 · Clinical Nutrition ESPEN
  41. Natural Insulin Sensitizers for the Management of Diabetes Mellitus: A Review of Possible Molecular Mechanisms
    Habib Yaribeygi, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2021 · Advances in experimental medicine and biology
  42. Connections between body composition and dysregulation of islet α- and β-cells in type 2 diabetes
    Jia-xi Miao, Jiaping Xu, Rui Wang, Yu-xian Xu, Feng Xu, Chunhua Wang, Chao Yu, Dongmei Zhang, Jianbin Su · 2024 · Diabetology & Metabolic Syndrome
  43. Glucagon acutely stimulates hepatic gluconeogenesis
    Caroline Hansen, Josephine Fisker-Andersen, Christine Bruun Rasmussen, Frederik R. Ceutz, Jens Juul Holst, Marie Winther‐Sørensen, Nicolai J. Wewer Albrechtsen · 2025 · Peptides
  44. Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health
    Robert J. Wagner, Sabine S. Eckstein, Louise Fritsche, Katsiaryna Prystupa, Sebastian Hörber, Hans‐Ulrich Häring, Andreas L. Birkenfeld, Andreas Peter, Andreas Fritsche, Martin Heni · 2022 · Frontiers in Endocrinology
  45. Comparative Effect of Insulin Resistance Reduction and Hormonal Alterations on Type 2 Diabetes Remission After Bariatric Surgery
    Ekaterina Alekseevna Shestakova, Iurii Stafeev, Yury Yashkov, A. Yurasov, Alina Tomilova, Yelena V. Parfyonova, Marina Vladimirovna Shestakova, Ivan Ivanovich Dedov · 2024 · Journal of Clinical Medicine
  46. Glucagon and Liver Fat are Downregulated in Response to Very Low-calorie Diet in Patients with Obesity and Type-2 Diabetes
    Stephan Haas, Patrik Löfgren, Per I Stal, Johan Hoffstedt · 2020 · Experimental and Clinical Endocrinology & Diabetes
  47. Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test
    Anna Elisabet Jonsson, Sara Elizabeth Stinson, Signe S. Torekov, Tine Dalsgaard Clausen, Kristine Færch, Louise Kelstrup, Niels Grarup, Elisabeth Reinhardt Mathiesen, Peter Damm, Daniel R. Witte et al. · 2021 · BMC Medical Genomics
  48. Islet isograft transplantation improves insulin sensitivity in a murine model of type 2 diabetes
    Monica Young Choi, Seong Jun Lim, Mi Joung Kim, Yu‐Mee Wee, Hyunwook Kwon, Chang Hee Jung, Young Hoon Kim, Duck Jong Han, Sung Hoon Shin · 2021 · Endocrine
  49. GPR41 and GPR43 modulate rodent pancreatic α-cell function and growth
    A Sánchez-Roncero, Tamara Fernández‐Marcelo, Atenea Alexandra Perez-Serna, María Ángeles Martín, Omaira Alberquilla, Rebeca Sánchez‐Domínguez, Jose Carlos Segovia, Fernando Escrivá, Beatriz G. Gálvez, Carmen Álvarez et al. · 2025 · Life Sciences
  50. Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery
    Amanda Finn, Yenni E. Cedillo, Marthe Isaksen Aukan, Barbara Ann Gower, Cátia Martins · 2025 · Obesity
  51. Antidiabetic and Anti-Inflammatory Potential of Zingiberaceae Plants in Dietary Supplement Interventions
    Natalia Kuzia, Olga Adamska, Natalia Ksepka, Agnieszka Wierzbicka, Artur Jóźwik · 2026 · Molecules
  52. Nonlinear HbA1c thresholds reveal accelerated atherogenic remodeling and improved risk reclassification in type 2 diabetes
    Vehbi Şirikçi, Hüseyin Avni Fındıklı · 2026 · Frontiers in Cardiovascular Medicine
  53. Assessment of Islet Alpha- and Beta-Cell Function
    Sten Madsbad, Jens Juul Holst · 2019 · Springer eBooks
  54. Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
    Rasmus Stenlid, Hannes Manell, Rikard Seth, Sara Y. Cerenius, Azazul Islam Chowdhury, Camilla Roa Cortés, Isabelle Nyqvist, Thomas Lundqvist, Maria Halldin, Peter Bergsten · 2023 · Metabolites
  55. Intra-pancreatic fat is associated with high circulating glucagon and GLP-1 concentrations following whey protein ingestion in overweight women with impaired fasting glucose: A randomised controlled trial
    Jia Jiet Lim, Ivana Roosevelt Sequeira, Wilson C.Y. Yip, Louise Weiwei Lu, Jennifer Lynn Miles-Chan, Sally D. Poppitt · 2023 · Diabetes Research and Clinical Practice
  56. Pathogenesis and therapeutic effect of sitagliptin in experimental diabetic model of COVID-19
    Qinghe Meng, Ikechukwu B. Jacob, Chunyan Wang, Julia Ma, Liye Suo, Wenlu Zhao, Akinkunmi O. Lawal, Yuqi Song, Guirong Wang, Robert N. Cooney · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  57. Impaired Glucagon Suppression Accompanied by Liver Fat Accumulation Mediated Worse Blood Glucose Control in Patients With T2D
    Shuang Li, Jingfei Liu, Chun Yang, Yanjun Jin, Yiwen Zhou, Hang Zhao, Zhangyao Su, Yu Fu, Mei Zhang, XianYong Yin et al. · 2025 · The Journal of Clinical Endocrinology & Metabolism
  58. Increased serum cystatin C levels and responses of pancreatic α- and β-cells in type 2 diabetes
    Hui-qing Yuan, Jia-xi Miao, Jia-ping Xu, Su-xiang Zhu, Feng Xu, Xiao-hua Wang, Chun-hua Wang, Chao Yu, Xue-qin Wang, Jian-bin Su et al. · 2022 · Endocrine Connections
  59. Exploring diabetics II inhibitors based on benzodioxin derivatives, structure activity relationship, molecular docking and ADME property study
    Maryam Ali Al-Abdulbaqi, Muhammad Taha, Fazal Rahim, Imad Uddin, Nizam Uddin, Abdul Wadood, Sana Haq, Naveed Iqbal, Khalid Mohammed Khan, Syed Adnan Alı Shah et al. · 2024 · Journal of Molecular Structure
  60. Effect of probiotic-fermented milk containing Lactiplantibacillus pentoses strain HBUAS 53657 on serum glutathione peroxidase activity and pancreatic histopathology in hyperglycemic rats
    Rita Yaswir, Eti Yerizel, Netti Suharti, Cimi Ilmiawati · 2024 · Acta Biochimica Indonesiana
  61. Glucagon and the metabolic syndrome
    Andrew Welch, Adrian V Vella · 2024 · Elsevier eBooks
  62. Insulin:Glucagon Bipolar Axis in Obesity With a Glimpse Into Its Association With Insulin Resistance in Different Glucose Tolerance States
    John Lyngdoh, Happy Chutia, Shanthosh Priyan Sundaram, Vijaya Lakshmi, Alice Abraham Ruram, Kyrshanlang Giri Lynrah · 2024 · Cureus
  63. Therapeutic potentials of glucose-dependent insulinotropic polypeptide (GIP) in T2DM: Past, present, and future
    Soumik Das, Harini Ravi, Achsha Babu, Manosi Banerjee, Kanagavalli Ramasubbu, Dhanasekaran Sivaraman, Vijayarangan Devi Rajeswari, Ganesh Venkatraman, Gnanasambandan Ramanathan · 2024 · Advances in protein chemistry and structural biology
  64. Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
    Thomas Pixner, Tatsiana Chaikouskaya, Wanda Lauth, Georg Zimmermann, Katharina Mörwald, Julia Lischka, Dieter Furthner, Elisabeth Awender, Sabine Geiersberger, Katharina Maruszczak et al. · 2024 · Frontiers in Endocrinology
  65. Diabetes-associated Genetic Variation in MTNR1B and Its Effect on Islet Function
    Max Vella, Sneha Mohan, Hannah E. Christie, Kent R. Bailey, Claudio Cobelli, Chiara Dalla Man, Aleksey V. Matveyenko, Aoife Maria Egan, Adrian V Vella · 2024 · Journal of the Endocrine Society
  66. Pancreatic α‐cell dysfunction associated with equine insulin dysregulation
    Sanna S. Lindåse, Emma M. Strage, Josefin Söder, Johan T. Bröjer · 2026 · Equine Veterinary Journal
  67. Insulin resistance and metabolic diseases - a review
    Marta Drabczyk, Kamila Kosyra, Inga MAGDA, Zuzanna Marczyńska, Antoni Zyśk · 2024 · Journal of Education Health and Sport
  68. Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development
    Helena Kontola, Luís Crisóstomo, Eliisa Löyttyniemi, Jaakko J. Koskenniemi, Riitta Veijola, Jorma Toppari, Jukka T. Kero · 2025 · The Journal of Clinical Endocrinology & Metabolism
  69. Subjects with high fasting insulin also have higher postprandial GLP-1 and glucagon levels than controls with lower insulin.
    Erina Albinsson-Stenholm, Johannes Bergsén, Simon Ingves, Nathalie Vilhelmsson, Hans Guldbrand, F. Nystrom · 2019 · Nutrition Research
  70. Serum Glucose Measurement after Five to Six Hours is Comparable to Eight Hours Fasting in Ramadan
    Ammar Almomin, Samih Abed Odhaib, Mahmood Thamer Altemimi, Hussein Ali Nwayyir, Ibrahim Hani Hussein, Haider Ayad Alidrisi, Nassar Taha Yaseen Alibrahim, Abbas Ali Mansour · 2021 · Sultan Qaboos University medical journal
  71. The experience of Avicenna and possibility to improve the diabetes treatment
    Mizhgona Umedzhonovna Sharofova · 2017 · Reviews on Clinical Pharmacology and Drug Therapy
  72. Efeitos da manipulação aguda dos ácidos graxos na secreção de insulina induzida pelas incretinas em voluntários com e sem diabetes tipo 2
    Valéria Bahdur Chueire · 2018
  73. Potential Health Benefits of Rice By-products
    Bee Ling Tan, Mohd Esa Norhaizan · 2020 · Springer eBooks
  74. PFKFB3 Depletion Activates β-Cell Replication by Cell Competitive Culling of Compromised β-Cells Under Stress
    Jie Min, Feiyang Ma, Matteo A. Pellegrini, Oppel B.W. Greeff, Salvador Moncada, Slavica Tudzarova · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Role of fasting duration and weekday in incretin and glucose regulation
    Kim Katrine Bjerring Clemmensen, Jonas Salling Quist, Dorte Vistisen, Daniel R. Witte, Anna Elisabet Jonsson, Oluf Borbye Pedersen, Torben F. Hansen, Jens Juul Holst, Torsten Lauritzen, Marit E. Jørgensen et al. · 2021 · Endocrine Abstracts
  76. Reclassifying or Declassifying Diabetes? Can Clinical Characteristics Guide Classification and Treatment?
    Adrian V Vella · 2021
  77. 「腎疾患対策検討会報告書」が示す今後の慢性腎臓病対策 (特集 知っていますか? 慢性腎臓病(CKD))
    明 菱田 · 2008 · 食生活
  78. Terminalia catappa reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/ streptozotocin-induced diabetic rats
    Franklyn Nonso Iheagwam, Olawumi Toyin Iheagwam, Michael Kemjika Onuoha, Olubanke Olujoke Ogunlana, Shalom Nwodo Chinedu · 2022 · Research Square
  79. Insulinorésistance et glucagon
    Fokina V.A. · 2016 · Médecine des Maladies Métaboliques
  80. Hepatic Glucagon Receptor Signaling Controls Amino Acid Metabolism and Regulates Alpha Cell Mass
    Emilie Elmelund, Katrine Douglas Galsgaard, Christian Dall Johansen, Samuel A.J. Trammell, Anna B. Bomholt, Marie Winther‐Sørensen, Jenna Elizabeth Hunt, Charlotte Mehlin Sørensen, Thomas Kruse, Jesper F. Lau et al. · 2022 · SSRN Electronic Journal
  81. Glucagon kinetics assessed by mathematical modelling during oral glucose administration in people spanning from normal glucose tolerance to type 2 diabetes
    Francesco Andreozzi, Elettra Mancuso, Mariangela Rubino, Benedetta Salvatori, Micaela Morettini, Giuseppe Monea, Christian S. Göbl, Gaia Chiara Mannino, Andrea Tura · 2024 · Frontiers in Endocrinology
  82. Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus
    Lina Chang, Xiaohui Ma, Menghua Yuan, Li Ding, Yian Gu, Lili Liu, Yan Li, Hua Shu, Ming Rong Liu, Qing He · 2024 · Diabetes Metabolic Syndrome and Obesity
  83. Antidiabetic Potentials of Catechin in Combination with Metformin: An In vitro and Molecular Docking Study
    Jyoshna Rani Dash, Gurudutta Pattnaik, Sovan Pattanaik, Goutam Ghosh, Goutam Rath, Biswakanth Kar · 2024 · Current Bioactive Compounds
  84. Glucagon change rate after glucose load: a potential key for tailoring treatment in gestational diabetes mellitus
    Sae Joko, Takuya Hashimoto, Miho Yamashita, Daisuke Tsuriya, Masato Maekawa, Moriya Iwaizumi · 2025 · Diabetology International
  85. Glucagon: a potential protective factor against peripheral nerve compromise in patients with type 2 diabetes and obesity
    Hao Hua, Rui Wang, Yuxian Xu, Feng Xu, Chun‐Hua Wang, Li-hua Zhao, Lihua Wang, Chengwei Duan, Jianbin Su · 2025 · Diabetology & Metabolic Syndrome
  86. Is Impaired Suppression of Glucagon a Predictive Marker of Glucose Intolerance?
    Fabrizia Carli, Amalia Gastaldelli · 2025 · The Journal of Clinical Endocrinology & Metabolism
  87. The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for prediabetes: a multi-center retrospective cohort study
    F.Y. Ma, Ruwen Wang, Ru Wang · 2025 · Frontiers in Nutrition
  88. Loss of Slc39a5 in α-cells impairs glucose metabolism by chronically increasing glucagon
    Wenli Kelly Chen, Weiyi Cui, Yan Jun Xu, Xuelian Wang, Xueting Sun, Jing Ren, Ning Hou, Wenyong Xiong, Rui‐Ping Xiao, Xiuqin Zhang · 2025 · Journal of Advanced Research
  89. Uncovering metabolic shifts: an ¹H-NMR study on the dual influence of HIV/TB coinfection and ART
    Steven Patrick Ahumada Prado, Shayne Mason, Robin Wood, Laneke Luies · 2025 · BMC Infectious Diseases
  90. Additional file 6 of A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes
    Chen, Bo, Jingjing Zeng, Fan, Menglin, Qiqi You, Wang, Chenyue, Wang, Ke, Minghui Qin, Shaoyong Xu · 2024 · Figshare
  91. Additional file 1 of Association of LDL:HDL ratio with prediabetes risk: a longitudinal observational study based on Chinese adults
    Maobin Kuang, Peng, Nan, Jiajun Qiu, Yanjia Zhong, Zou, Yang, 盛国太 · 2022 · Figshare
  92. Additional file 4 of A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes
    Chen, Bo, Jingjing Zeng, Fan, Menglin, Qiqi You, Wang, Chenyue, Wang, Ke, Minghui Qin, Shaoyong Xu · 2024 · Figshare
  93. Additional file 7 of A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes
    Chen, Bo, Jingjing Zeng, Fan, Menglin, Qiqi You, Wang, Chenyue, Wang, Ke, Minghui Qin, Shaoyong Xu · 2024 · Figshare
  94. Additional file 3 of A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes
    Chen, Bo, Jingjing Zeng, Fan, Menglin, Qiqi You, Wang, Chenyue, Wang, Ke, Minghui Qin, Shaoyong Xu · 2024 · Figshare
  95. Additional file 5 of A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes
    Chen, Bo, Jingjing Zeng, Fan, Menglin, Qiqi You, Wang, Chenyue, Wang, Ke, Minghui Qin, Shaoyong Xu · 2024 · Figshare
  96. Additional file 3 of Connections between body composition and dysregulation of islet α- and β-cells in type 2 diabetes
    Miao, Jia-xi, jiaping xu, Wang, Rui, Xu, Yu-xian, Xu, Feng, Wang, Chun-hua, Yu, Chao, Zhang, Dong-mei, Jianbin Su · 2024 · Figshare
  97. Additional file 2 of Connections between body composition and dysregulation of islet α- and β-cells in type 2 diabetes
    Miao, Jia-xi, jiaping xu, Wang, Rui, Xu, Yu-xian, Xu, Feng, Wang, Chun-hua, Yu, Chao, Zhang, Dong-mei, Jianbin Su · 2024 · Figshare
  98. Additional file 6 of Connections between body composition and dysregulation of islet α- and β-cells in type 2 diabetes
    Miao, Jia-xi, jiaping xu, Wang, Rui, Xu, Yu-xian, Xu, Feng, Wang, Chun-hua, Yu, Chao, Zhang, Dong-mei, Jianbin Su · 2024 · Figshare
  99. Additional file 1 of Connections between body composition and dysregulation of islet α- and β-cells in type 2 diabetes
    Miao, Jia-xi, jiaping xu, Wang, Rui, Xu, Yu-xian, Xu, Feng, Wang, Chun-hua, Yu, Chao, Zhang, Dong-mei, Jianbin Su · 2024 · Figshare
  100. Additional file 5 of Connections between body composition and dysregulation of islet α- and β-cells in type 2 diabetes
    Miao, Jia-xi, jiaping xu, Wang, Rui, Xu, Yu-xian, Xu, Feng, Wang, Chun-hua, Yu, Chao, Zhang, Dong-mei, Jianbin Su · 2024 · Figshare